Conference Coverage

Diabetes educators enhance care, improve outcomes in the primary care settings


 

AT THE ADA ANNUAL SCIENTIFIC SESSIONS

References

The Remedy Study was funded by the ADA. Dr. Zgibor reported having no other disclosures. Dr. Siminerio reported receiving research support from Becton, Dickinson and Co.

sworcester@frontlinemedcom.com

Pages

Recommended Reading

Angina drug ranolazine lowers glucose in type 2 diabetes
MDedge Endocrinology
YMCA prediabetes program results in weight loss, lower costs
MDedge Endocrinology
AATS: Metformin linked to better progression-free survival in early-stage NSCLC
MDedge Endocrinology
Diet coaching curbs weight gain in women at GDM risk
MDedge Endocrinology
Costs and effects of diabetes on longevity vary across demographics, BMI
MDedge Endocrinology
Distress bears on clinical outcomes in diabetes
MDedge Endocrinology
Bariatric surgery beats lifestyle changes alone for type 2 diabetes
MDedge Endocrinology
Study quantifies risks linked to cardiac multimorbidity
MDedge Endocrinology
ADA: Alefacept slows progress of type 1 diabetes 15 months post-treatment
MDedge Endocrinology
ADA: Intensive lifestyle interventions save costs in highest-risk adults
MDedge Endocrinology